gliclazide has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, JX; Ge, XP; Sun, Y; Wang, Z; Zhang, XH | 1 |
| Fu, J; Huang, Z; Li, B; Sun, Y; Wang, Z; Zhang, X | 1 |
2 other study(ies) available for gliclazide and Multiple Myeloma
| Article | Year |
|---|---|
Connexin 43 gap junction affects survival and drug resistance of multiple myeloma side population cells.
Topics: Connexin 43; Drug Resistance; Gap Junctions; Humans; Multiple Myeloma; Side-Population Cells | 2023 |
Up-regulation of connexin-43 expression in bone marrow mesenchymal stem cells plays a crucial role in adhesion and migration of multiple myeloma cells.
Topics: Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Connexin 43; Gene Expression Regulation, Neoplastic; Glycyrrhetinic Acid; Humans; Mesenchymal Stem Cells; Multiple Myeloma; Up-Regulation | 2015 |